Akme Fintrade Sees Credit Rating Assignments and Upgrades Across Debt Instruments
Akme Fintrade (India) Ltd reported credit ratings for its debt instruments, noting assignments and upgrades across bank loans, non-convertible debentures, and commercial paper as of April 08, 2026.The company detailed the credit rating profile for different product segments. The rating assessment covered a total outstanding quantum of Rs. 855 Cr, with zero amount reported as withdrawn.
The credit ratings are presented below:
| Product | Quantum (Rs Cr) | Long Term Rating | Short Term Rating |
|---|---|---|---|
| Bank Loan Ratings | 355 | ACUITE A- Stable Assigned | - |
| Bank Loan Ratings | 180 | ACUITE A- Stable Upgraded | - |
| Non-Convertible Debentures (NCD) | 200 | ACUITE A- Stable Assigned | - |
| Non-Convertible Debentures (NCD) | 100 | ACUITE A- Stable Upgraded | - |
| Commercial Paper (CP) | 20 | - | ACUITE A2+ Assigned |
| Total Outstanding Quantum (Rs. Cr) | 855 | - | - |
| Total Withdrawn Quantum (Rs. Cr) | 0 | - | - |
For the two tranches of Bank Loan Ratings, one quantum of Rs. 355 Cr received an ACUITE A- Stable Assigned rating for the long term. Additionally, a quantum of Rs. 180 Cr was assigned an ACUITE A- Stable Upgraded rating for the long term.
Regarding Non-Convertible Debentures (NCD), the structure with a quantum of Rs. 200 Cr was rated ACUITE A- Stable Assigned for the long term. Similarly, an NCD quantum of Rs. 100 Cr received an ACUITE A- Stable Upgraded long term rating.
For the Commercial Paper (CP) instrument, a quantum of Rs. 20 Cr was assigned a Short Term Rating of ACUITE A2+ Assigned.
AFIL Stock Price Movement
Shares of Akme Fintrade (India) Limited are edging higher to ₹9.00 as of 11:37 AM today, rebounding to gain 2.04% in live trading. The stock sustains momentum, trading on robust volume exceeding 1.05 million shares during the ongoing session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.